play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left
  • cover play_arrow

    Music 24/7 - Feel the vibe
    Online Radio

  • cover play_arrow

    Talk Shows - Stay Updated
    Online Radio

  • cover play_arrow

    Pillars and Plants - Gospel
    Online Radio

  • cover play_arrow

    Audio Stories - A new movie experience
    Online Radio

  • cover play_arrow

    Welcome to the Leading Lifestyle Internet Radio
    Online Radio

  • Home
  • keyboard_arrow_right News
  • keyboard_arrow_right Pfizer: Three Doses Of Our COVID Vaccine Effective Against Omicron Variant

News

Pfizer: Three Doses Of Our COVID Vaccine Effective Against Omicron Variant

Online Radio December 8, 2021 17


Background
share close

Pfizer and BioNTech have announced that three doses of its COVID-19 vaccine provides sufficient protection against the Omicron variant.

Since the new strain was discovered and its designation as a variant of concern (VOC) by the World Health Organisation (WHO), there have been concerns about how effective current vaccines are against it.

In a statement on Wednesday, the companies said blood tests from persons who received the booster dose showed that it neutralised the Omicron variant to levels that are comparable to previous versions of the virus after two doses.

“Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant,” the statement reads.

“A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold.”

The companies, however, said they believe that individuals who received two doses may still be protected against severe forms of the disease, adding that they are closely monitoring real-world effectiveness against Omicron.

“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” Albert Bourla, Pfizer chief executive officer, said.

“Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”

The companies also said an Omicron-specific version of the anti-coronavirus vaccine, currently in development by BioNTech, would be available by March.

Tagged as: , , .

Rate it
Previous post
Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *